Use your antibodies-online credentials, if available.
Il n’y a pas de produits dans votre liste de comparaison.
Votre panier est vide.
Afficher toutes les espèces
Afficher tous les synonymes
Sélectionnez vos espèces et l'application
anti-Mouse (Murine) Anticorps:
anti-Rat (Rattus) Anticorps:
Vous arrivez à notre recherche pré-filtrée.
Human Polyclonal ADRBK1 Primary Antibody pour IHC (p), WB - ABIN1882061
Eichmann, Lorenz, Hoffmann, Brockmann, Krasel, Lohse, Quitterer: The amino-terminal domain of G-protein-coupled receptor kinase 2 is a regulatory Gbeta gamma binding site. dans The Journal of biological chemistry 2003
Show all 6 Pubmed References
Human Monoclonal ADRBK1 Primary Antibody pour ICC, IHC - ABIN969178
Chen, Long, Wu, Jiang, Ma: EGF transregulates opioid receptors through EGFR-mediated GRK2 phosphorylation and activation. dans Molecular biology of the cell 2008
Show all 2 Pubmed References
Human Polyclonal ADRBK1 Primary Antibody pour ELISA, WB - ABIN251302
Iaccarino, Barbato, Cipolletta, De Amicis, Margulies, Leosco, Trimarco, Koch: Elevated myocardial and lymphocyte GRK2 expression and activity in human heart failure. dans European heart journal 2005
Cow (Bovine) Monoclonal ADRBK1 Primary Antibody pour IHC (fro), IF - ABIN534096
Pitcher, Freedman, Lefkowitz: G protein-coupled receptor kinases. dans Annual review of biochemistry 1998
Show all 3 Pubmed References
Human Monoclonal ADRBK1 Primary Antibody pour IF, IHC - ABIN966226
Sterne-Marr, Leahey, Bresee, Dickson, Ho, Ragusa, Donnelly, Amie, Krywy, Brookins-Danz, Orakwue, Carr, Yoshino-Koh, Li, Tesmer: GRK2 activation by receptors: role of the kinase large lobe and carboxyl-terminal tail. dans Biochemistry 2009
Show all 2 Pubmed References
Enhanced GRK2 expression triggers cardiac hypertrophy by GRK2-PI3Kgamma mediated Akt phosphorylation and subsequent inactivation of GSK3beta.
Grk2 rescuing activity requires the integrity of domains essential for its interaction with GPCRs, we speculate that Grk2 may regulate Hh pathway activity by downregulation of a GPCR.
The main novelty presented here is to show that septic shock induces cardiac hyporesponsiveness to isoproterenol by a mechanism dependent on nitric oxide and mediated by G protein-coupled receptor (Montrer GPR34 Anticorps) kinase isoform 2. Therefore, G protein-coupled receptor (Montrer GPR34 Anticorps) kinase isoform 2 inhibition may be a potential therapeutic target in sepsis-induced cardiac dysfunction.
Data, including data from studies in heterozygous knockout mice, suggest that Grk2 is involved in TNFalpha (Montrer TNF Anticorps)-induced wound healing in epithelial cells of the colon; Grk2 appears to inhibit TNFalpha (Montrer TNF Anticorps)-induced apoptosis; Grk2 inhibits TNFalpha (Montrer TNF Anticorps)-induced ERK (Montrer EPHB2 Anticorps) activation by inhibiting generation of reactive oxygen species. Homozygous knockout of Grk2 is embryonically lethal in mice.
GRK2 upregulation causes kappa-opioid receptor (Montrer OPRK1 Anticorps) desensitization in diabetic heart
study provides the first insights into the role of GRK2 in skeletal muscle physiology and points to a role for GRK2 as a modulator of contractile properties in skeletal muscle as well as beta2AR (Montrer ADRB2 Anticorps)-induced hypertrophy.
GRK2 loss confers a protective advantage over control mice after myocardial ischemia/reperfusion injury. Fibroblast GRK2 knockout mice presented with decreased infarct size and preserved cardiac function 24 hours post ischemia/reperfusion. They had decreased fibrosis and fibrotic gene expression. These protective effects correlated with decreased infiltration of neutrophils to the ischemia site and decreased TNF-alpha (Montrer TNF Anticorps).
this study shows that astragaloside IV alleviates E. coli-caused peritonitis through modulating GRK2-CXCR2 (Montrer CXCR2 Anticorps) signal in neutrophils
GRK2 down-regulation is cardioprotective during diet-induced obesity, reinforcing the protective effect of maintaining low levels of GRK2 under nutritional stress, and showing a role for this kinase in obesity-induced cardiac remodeling and steatosis.
The betaARKrgs peptide, but not endogenous GRK2, interacted with Galpha(q (Montrer GNAQ Anticorps)) and interfered with signaling through this G protein. These data support the development of GRK2-based therapeutic approaches to prevent hypertrophy and heart failure.
The PIP2-induced orientation of the GRK2-Gbeta1gamma2 complex is therefore most likely caused by specific interactions between PIP2 and the GRK2 PH domain.
Mitochondrial-targeted GRK2 is essential for prodeath signaling occurring after oxidative stress in myocytes and assigning a novel role for this GRK (Montrer GRK4 Anticorps).
Indicate that the anti-proliferative function of elevated GRK2 in hepatocellular carcinoma is associated with delayed cell cycle progression and is GRK2 kinase activity-dependent.
G alpha q/11 interacts with this protein. A novel surface on a regulator of G protein signals a homology domain for binding G alpha subunits (GRK2 kinase}
determined the crystallographic structure of GRK2 in complex with G protein beta1gamma2 subunits.
intramolecular interactions could play a role in regulating G protein-coupled receptor kinase 2 (GRK2).
epithelial Na-channels are maintained in the active state by Grk2; Grk2 phosphorylates the C terminus of the channel beta subunit (Montrer POLG Anticorps) and renders the channels insensitive to inhibition by Nedd4-2 (Montrer NEDD4L Anticorps).
Crystallographic and biochemical studies provide evidence that the major domain interfaces of G protein-coupled beta adrenergic receptor kinase 1 (GRK2) remain associated during Gbetagamma binding and activation of GRK2.
Resultrs suggest that activated platelet-derived growth factor receptor-beta (Montrer PDGFRB Anticorps) (PDGFRbeta) phosphorylates GRK2 tyrosyl residues and thereby activates GRK2, which then serine-phosphorylates and desensitizes the PDGFRbeta.
GRK2-as5 has a role in membrane trafficking of the mu-opioid receptor (Montrer OPRM1 Anticorps)
Chronic/pathologic GPCR (Montrer NMUR1 Anticorps) signaling elicits the interaction of the G-protein Gbetagamma subunit with GPCR (Montrer NMUR1 Anticorps) kinase 2 (GRK2), targeting the receptor for internalization, scaffolding to pathologic signals, and receptor degradation. Targeting this pathologic Gbetagamma-GRK2 interaction has been suggested as a possible strategy for the treatment of HF.
A novel regulatory role of GRK2 was proposed for the ubiquitination of beta-arrestin in the context of the PKC-mediated heterologous regulation of GPCRs.
eIF3d (Montrer EIF3D Anticorps) promotes gallbladder cancer (GBC) progression mainly via eIF3d (Montrer EIF3D Anticorps)-GRK2-AKT (Montrer AKT1 Anticorps) axis and it may be used as a prognostic factor. The therapeutic targeting of eIF3d (Montrer EIF3D Anticorps)-GRK2 axis may be a potential treatment approach for GBC.
KHSV miR (Montrer MLXIP Anticorps)-K3 activates the GRK2/CXCR2 (Montrer CXCR2 Anticorps)/AKT (Montrer AKT1 Anticorps) axis inducing KSHV-induced angiogenesis and promoting KSHV latency.
Compared to the original peptide, a modified peptide (Ac-EEMEFSEAEANMN-NH2) exhibited markedly higher affinity for GRK2, but very low affinity for GRK5 (Montrer GRK5 Anticorps), suggesting that it can be a sensitive and selective peptide for GRK2
Low grk2 expression is associated with lung metastasis in gastric cancer.
Lowering the level of cellular FLNA (Montrer FLNA Anticorps) caused an elevation in RalA (Montrer rala Anticorps) activity and resulted in selective interference with the normal intracellular trafficking and signaling of D2R (Montrer DRD2 Anticorps) through GRK2.
Results demonstrate that GPR3 (Montrer GPR3 Anticorps) signals at the plasma membrane and can be silenced by GRK2/beta-arrestin overexpression. These results also strongly implicate the serine and/or threonine residues in the third intracellular loop in the regulation of GPR3 (Montrer GPR3 Anticorps) activity.
GRK2 is negatively related to IGF1R (Montrer IGF1R Anticorps) and IGF1R (Montrer IGF1R Anticorps), but not GRK2, was associated with the tumour-node-metastasis stage and overall and disease-free survival in hepatocellular carcinoma.
The tyrosine-phosphorylated GRK2 mediates this inhibition by acting on the second intracellular loop of D3R.
The product of this gene phosphorylates the beta-2-adrenergic receptor and appears to mediate agonist-specific desensitization observed at high agonist concentrations. This protein is an ubiquitous cytosolic enzyme that specifically phosphorylates the activated form of the beta-adrenergic and related G-protein-coupled receptors. Abnormal coupling of beta-adrenergic receptor to G protein is involved in the pathogenesis of the failing heart.
beta-adrenergic receptor kinase 1
, adrenergic, beta, receptor kinase 1
, G-protein-coupled receptor kinase 2
, beta ARK
, beta ARK1
, beta-AR kinase-1
, beta-adrenergic receptor kinase-1
, G-protein coupled receptor kinase 2
, adrenergic receptor kinase, beta 1
, beta-adrenergic receptor kinase 1 beta ARK1